ATE397662T1 - Neues polypeptid, dafür kodierende dna und deren verwendungen - Google Patents

Neues polypeptid, dafür kodierende dna und deren verwendungen

Info

Publication number
ATE397662T1
ATE397662T1 AT98905674T AT98905674T ATE397662T1 AT E397662 T1 ATE397662 T1 AT E397662T1 AT 98905674 T AT98905674 T AT 98905674T AT 98905674 T AT98905674 T AT 98905674T AT E397662 T1 ATE397662 T1 AT E397662T1
Authority
AT
Austria
Prior art keywords
polypeptide
dna coding
new polypeptide
antibody
dna
Prior art date
Application number
AT98905674T
Other languages
English (en)
Inventor
Hideaki Tada
Mikio Konishi
Daikichi Fukushima
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of ATE397662T1 publication Critical patent/ATE397662T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT98905674T 1997-02-27 1998-02-26 Neues polypeptid, dafür kodierende dna und deren verwendungen ATE397662T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4314397 1997-02-27

Publications (1)

Publication Number Publication Date
ATE397662T1 true ATE397662T1 (de) 2008-06-15

Family

ID=12655623

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98905674T ATE397662T1 (de) 1997-02-27 1998-02-26 Neues polypeptid, dafür kodierende dna und deren verwendungen

Country Status (9)

Country Link
US (3) US7396908B2 (de)
EP (1) EP0990703B1 (de)
KR (1) KR20000075749A (de)
AT (1) ATE397662T1 (de)
DE (1) DE69839582D1 (de)
DK (1) DK0990703T3 (de)
ES (1) ES2307313T3 (de)
PT (1) PT990703E (de)
WO (1) WO1998038304A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011791A2 (en) * 1997-09-05 1999-03-11 University Of Washington Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
WO1999013078A1 (en) * 1997-09-12 1999-03-18 Biogen, Inc. Cysteine rich receptors-train
JP2002508934A (ja) * 1997-12-29 2002-03-26 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Ｔｎｆレセプターに対して相同性を有する、新規な核酸およびポリペプチド
JP2002528046A (ja) * 1998-01-27 2002-09-03 ミレニアム・フアーマシユーチカルズ・インコーポレーテツド 新規レセプタースーパーファミリー分子およびそれについての用途
AU2574200A (en) * 1999-02-19 2000-09-04 Toshio Kitamura Novel tnf receptor-like proteins
CA2381327A1 (en) * 1999-07-16 2001-01-25 Steven M. Ruben Human tumor necrosis factor receptors tr13 and tr14
US6951738B2 (en) 1999-07-16 2005-10-04 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR13 and TR14
WO2001058954A2 (en) * 2000-02-11 2001-08-16 Genetics Institute, Llc. Trade molecules and uses related thereto
JP5060293B2 (ja) 2004-08-03 2012-10-31 バイオジェン・アイデック・エムエイ・インコーポレイテッド 神経機能におけるｔａｊ
US9434783B2 (en) * 2012-07-18 2016-09-06 Apogenix Ag Shortened CD95-Fc variant fusion proteins, nucleic acids and host cells thereof
KR102209958B1 (ko) † 2012-10-24 2021-02-01 바스프 에스이 액상으로의 아민의 포스겐화에 의한 이소시아네이트의 제조 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9214857D0 (en) 1992-07-13 1992-08-26 Medical Res Council Human nucleic acid fragments and their use
WO1999013078A1 (en) * 1997-09-12 1999-03-18 Biogen, Inc. Cysteine rich receptors-train

Also Published As

Publication number Publication date
WO1998038304A1 (fr) 1998-09-03
US7705140B2 (en) 2010-04-27
DK0990703T3 (da) 2008-09-29
US20080175843A1 (en) 2008-07-24
DE69839582D1 (de) 2008-07-17
EP0990703A1 (de) 2000-04-05
EP0990703A4 (de) 2001-09-12
PT990703E (pt) 2008-08-27
US20040142423A1 (en) 2004-07-22
US7396908B2 (en) 2008-07-08
ES2307313T3 (es) 2008-11-16
US20100298546A1 (en) 2010-11-25
US8008451B2 (en) 2011-08-30
KR20000075749A (ko) 2000-12-26
EP0990703B1 (de) 2008-06-04

Similar Documents

Publication Publication Date Title
ATE444361T1 (de) Il-17 und il-17r homologe polypeptide und deren therapeutische verwendungen
HU9600692D0 (en) Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds
EP0994728A4 (de) Für die termini des beta-amyloids spezifische, rekombinante antikörper, dafür kodierende dna und verfahren zu ihrer verwendung
ES2193145T3 (es) Proteinas procoagulants quimericas.
DE69839444D1 (de) Smad 6 und dessen anwendungen
IL85878A0 (en) Anticoagulant proteins,dna coding for them,processes for preparing them,pharmaceutical compositions containing them,monoclonal antibodies against such proteins and hybrid cell lines which secrete these antibodies
DE69433690D1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
ATE397662T1 (de) Neues polypeptid, dafür kodierende dna und deren verwendungen
ATE242323T1 (de) Transportprotein, das den transport von kationischen xenobiotika und/oder pharmaka bewirkt, dafür kodierende dna-sequenzen und deren verwendung
EE200000151A (et) Aminoterminaalselt kärbitud rantes vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon
DK0817851T5 (da) DNA, der koder for humant papillomvirus type 18
BR0312889A (pt) Polipeptìdeo t20 peguilado
ATE385517T1 (de) Interferon ähnliche moleküle, und deren verwendungen
DK0781344T3 (da) Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme
EP0692532A4 (de) Neuartige polypeptide, ihre dna, rekombinanter vektor der letzter enthält, mit diesem hergestellter rekombinanter virus und seine verwendung
ATE190630T1 (de) Angiotensin-ii typ-1 rezeptor und dessen herstellung
WO1996009391A3 (en) Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19
NO980122L (no) Emaljematriksrelatert polypeptid
DE3853693D1 (de) DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
DE69941099D1 (de) Spezifische Nukleinsäuren und Polypeptide aus krankheitserregenden Stämmen von Neisseria
BR9911609A (pt) Proteìnas e genes de moraxella catarrhalis, antìgenos, anticorpos e usos
ATE111920T1 (de) Lymphokine, dns-sequenzen, die diese lymphokine kodieren, und sie enthaltende pharmazeutische zusammensetzungen.
EP1019500A4 (de) Neue ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
UA35624C2 (uk) МОЛЕКУЛА ДНК, ЩО КОДУЄ ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, ВЕКТОР, L-КЛІТИНА, ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, СПОСІБ ЙОГО ОТРИМАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, МОНОКЛОНАЛЬНЕ АНТИТІЛО

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0990703

Country of ref document: EP

REN Ceased due to non-payment of the annual fee